logo
Select company
Select metric
$ -3.73EBITDA per Share
VS
Market
7
Sector
17
Industry
21
History
93
$ 13.82Close
$ 6.5 - $ 17.02 52-Week Range
Ticker Information

Ticker

SRZN

Company Name

SURROZEN INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SURROZEN INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SRZN - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -31.83M$ -3.7318.54M
3/31/2025$ -78.74M$ -21.713.63M
12/31/2024$ -60.6M$ -20.6612.93M
9/30/2024$ -41.46M$ -12.8413.23M
6/30/2024$ -50.36M$ -15.9313.16M
3/31/2024$ -34.42M$ -16.5312.08M
12/31/2023$ -39.86M$ -19.7512.02M
9/30/2023$ -31.74M$ -15.6112.03M
6/30/2023$ -34.71M$ -17.3112M
3/31/2023$ -39.2M$ -19.6212M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SURROZEN INC's latest trailing twelve months (TTM) EBITDAPS stands at $ 0.
  • Over the past 5 years, SURROZEN INC's average EBITDAPS has been $ -16.87.
  • The median EBITDAPS for SURROZEN INC during this period was $ -18.47
  • SURROZEN INC reached its highest EBITDAPS over the past 5 years at $ -0.62.
  • The lowest EBITDAPS recorded by SURROZEN INC in the same timeframe $ -31.2

SURROZEN INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
CRVO : CERVOMED INC $ -2.53CUE : CUE BIOPHARMA INC $ -0.38TCRX : TSCAN THERAPEUTICS INC $ -1.01FATE : FATE THERAPEUTICS INC $ -1.31HYFT : MINDWALK HOLDINGS CORP $ -0.43CBUS : CIBUS INC $ -5.64VRCA : VERRICA PHARMACEUTICALS INC $ -4.06OVID : OVID THERAPEUTICS INC $ -0.51IRD : OPUS GENETICS INC $ -0.92BRNS : BARINTHUS BIOTHERAPEUTICS PLC $ -1.49

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for SURROZEN INC is calculated as follows: EBITDA [ $ 0 ] / (Shares WA [ 133.33K ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ 0 ]

SRZN - EBITDA per Share, Last 5 years

$ -31.2

Minimum

Dec 31, 2021

$ -0.62

Maximum

Dec 31, 2020

$ -16.87

Average

$ -18.47

Median

EBITDAPS Benchmark Analysis

The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -11.29
max$ 14.03
average$ 2.03
median$ 1
std$ 4.28